SteelPeak Wealth LLC Makes New $1.05 Million Investment in DaVita Inc. (NYSE:DVA)

SteelPeak Wealth LLC bought a new stake in DaVita Inc. (NYSE:DVA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,987 shares of the company's stock, valued at approximately $1,045,000.

Other institutional investors have also recently bought and sold shares of the company. Public Sector Pension Investment Board bought a new position in shares of DaVita during the 2nd quarter valued at about $235,000. MBB Public Markets I LLC bought a new position in DaVita during the second quarter worth about $582,000. The Manufacturers Life Insurance Company raised its stake in DaVita by 0.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 45,244 shares of the company's stock valued at $6,269,000 after acquiring an additional 150 shares during the period. Creative Planning boosted its holdings in shares of DaVita by 5.0% during the 2nd quarter. Creative Planning now owns 8,297 shares of the company's stock worth $1,150,000 after buying an additional 394 shares during the period. Finally, B. Riley Wealth Advisors Inc. grew its position in shares of DaVita by 78.9% in the second quarter. B. Riley Wealth Advisors Inc. now owns 4,130 shares of the company's stock valued at $572,000 after purchasing an additional 1,822 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

DaVita Stock Up 1.6 %

NYSE DVA traded up $2.85 during mid-day trading on Thursday, reaching $176.62. The stock had a trading volume of 551,467 shares, compared to its average volume of 546,704. The company has a fifty day moving average price of $159.25 and a 200 day moving average price of $154.62. DaVita Inc. has a 1 year low of $107.74 and a 1 year high of $178.75. The stock has a market cap of $14.48 billion, a PE ratio of 19.05, a price-to-earnings-growth ratio of 0.82 and a beta of 0.92. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the business earned $2.85 earnings per share. DaVita's revenue was up 4.6% compared to the same quarter last year. On average, research analysts expect that DaVita Inc. will post 9.71 earnings per share for the current year.

Wall Street Analyst Weigh In

DVA has been the subject of a number of analyst reports. Truist Financial boosted their price target on DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a research note on Monday, October 7th. Barclays raised their target price on DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.